In addition, LINC02257 regulates the nuclear translocation of YB1 by direct interacting and phosphorylating YB1, controlling the metastatic and proliferative abilities by LINC02257. Taken together, we demonstrate that LINC02257 is a promising therapeutic target for CRC treatment. The gene discussed is LINC01705; the disease is colorectal carcinoma.